COMMENTARY

Anti-VEGF Therapy for Retinal Vein Occlusions: New Trial Data

David M. Brown, MD

Disclosures

December 30, 2009

This feature requires the newest version of Flash. You can download it here.


Citation: Campochiaro P. Safety and efficacy of intravitreal ranibizumab (LUCENTIS) in patients with macular edema secondary to branch retinal vein occlusion: the BRAVO Study. Program and abstracts of Retina Congress 2009; September 30-October 4, 2009; New York, NY.

Brown D. Safety and efficacy of intravitreal ranibizumab (LUCENTIS) in patients with macular edema secondary to central retinal vein occlusion: CRUISE Study. Program and abstracts of Retina Congress 2009; September 30-October 4, 2009; New York, NY.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....